{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:11:45Z","timestamp":1790691105351,"version":"4.1.0"},"reference-count":225,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Scilex Holding Company andAveritas Pharma"},{"DOI":"10.13039\/100013038","name":"Department of Anesthesiology and Pain Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003579","name":"University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003579","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Averitas Pharma, Inc."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,1]]},"abstract":"Abstract<\/jats:title>\n \n Objective<\/jats:title>\n To evaluate available evidence for the efficacy and safety of topical analgesics for neuropathic pain and to offer treatment guidance.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n An expert panel searched PubMed (Medline) and reference lists of published articles for available literature assessing 8 categories of topical analgesics used to treat various neuropathic pain conditions. The panel rated the level of analgesic efficacy evidence for each treatment and considered safety, ease of use, and cost. The degree of consensus on the recommendations among the panelists was measured.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n There was strong evidence and high consensus that capsaicin 8% is effective for diabetic peripheral neuropathy and postherpetic neuralgia and that lidocaine is effective for postherpetic neuralgia. There was strong evidence and moderate consensus that capsaicin 8% could be effective for HIV-induced neuropathy. There was moderate evidence and high consensus that lidocaine is likely effective for diabetic peripheral neuropathy, idiopathic neuropathy, and postsurgical neuropathy and that capsaicin 8% might be effective for chemotherapy-induced peripheral neuropathy and complex regional pain syndrome. Evidence was weak for other topical medications, though the panel strongly agreed that antidepressants might help with postherpetic neuralgia, complex regional pain syndrome, postsurgical neuropathy, and post-traumatic neuropathy; that nonsteroidal anti-inflammatory drugs could help with postsurgical neuropathy; and that gabapentin might benefit vulvodynia. There was less agreement about whether antidepressants might benefit diabetic peripheral neuropathy, chemotherapy-induced peripheral neuropathy, and vulvodynia and whether capsaicin 8% could be effective for postsurgical neuropathy.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Recommendations were based on a survey and grading of existing literature and, when strong evidence was lacking, the collective clinical expertise of panelists.<\/jats:p>\n <\/jats:sec>","DOI":"10.1093\/pm\/pnaf130","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T12:06:45Z","timestamp":1758888405000},"page":"279-316","source":"Crossref","is-referenced-by-count":12,"title":["Topical analgesics for neuropathic pain: an evidence-informed guide for the practicing clinician"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7189-6411","authenticated-orcid":false,"given":"Erin","family":"Lawson","sequence":"first","affiliation":[{"name":"Coastal Pain and Spinal Diagnostics , Carlsbad, CA 92009,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Singla","sequence":"additional","affiliation":[{"name":"Anesthesiology and Pain Medicine, University of Virginia , Charlottesville, VA 22903,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Adler","sequence":"additional","affiliation":[{"name":"Division of Pain Medicine, Department of Anesthesiology, University of California San Diego , CA 92037,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E","family":"Argoff","sequence":"additional","affiliation":[{"name":"Comprehensive Pain Center, Albany Medical College , Albany, NY 12208,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6813-1515","authenticated-orcid":false,"given":"Jeffrey J","family":"Bettinger","sequence":"additional","affiliation":[{"name":"Pain Management, Saratoga Hospital Medical Group , Saratoga Springs, NY 12866,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Bhaskar","sequence":"additional","affiliation":[{"name":"Pain Management Centre, Charing Cross Hospital, Imperial College Healthcare NHS Trust , London W6 8RF,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hance","family":"Clarke","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Pain Management, Toronto General Hospital , Toronto, ON M5G 2C4,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Eidelman","sequence":"additional","affiliation":[{"name":"Neuromedicine Pain Division, University of Rochester Medical Center , Rochester, NY 14618,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Hirani","sequence":"additional","affiliation":[{"name":"Comprehensive Pain Center, Department of Anesthesiology and Perioperative Medicine, Oregon Health & Science University , Portland, OR 97239,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5645-6355","authenticated-orcid":false,"given":"W Michael","family":"Hooten","sequence":"additional","affiliation":[{"name":"Anesthesiology and Perioperative Medicine, Mayo Clinic College of Medicine , Rochester, MN 55905,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7254-4089","authenticated-orcid":false,"given":"Jordan","family":"Tishler","sequence":"additional","affiliation":[{"name":"Mass General Brigham, Harvard Medical School , Boston, MA 02115,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5647-6233","authenticated-orcid":false,"given":"Mark S","family":"Wallace","sequence":"additional","affiliation":[{"name":"Division of Pain Medicine, Department of Anesthesiology, University of California San Diego , CA 92037,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1126-2797","authenticated-orcid":false,"given":"Antje M","family":"Barreveld","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Tufts School of Medicine, Pain Medicine, Newton-Wellesley Hospital , Newton, MA 02459,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"2026053110314648700_pnaf130-B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fpain.2020.00001","article-title":"Neuropathic pain: challenges and opportunities","volume":"1","author":"van Velzen","year":"2020","journal-title":"Front Pain Res (Lausanne)"},{"issue":"6","key":"2026053110314648700_pnaf130-B2","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1212\/01.wnl.0000140708.62856.72","article-title":"Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"63","author":"Dubinsky","year":"2004","journal-title":"Neurology"},{"key":"2026053110314648700_pnaf130-B3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12871-015-0150-5","article-title":"Clinical practice guidelines for the management of neuropathic pain: a systematic review","volume":"16","author":"Deng","year":"2016","journal-title":"BMC Anesthesiol"},{"key":"2026053110314648700_pnaf130-B4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s40122-017-0091-4","article-title":"Pharmacotherapy for neuropathic pain: a review","volume":"6(Suppl. 1)","author":"Fornasari","year":"2017","journal-title":"Pain Ther"},{"issue":"4","key":"2026053110314648700_pnaf130-B5","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13040450","article-title":"Topical treatments and their molecular\/cellular mechanisms in patients with peripheral neuropathic pain\u2014narrative review","volume":"13","author":"Kocot-K\u0119pska","year":"2021","journal-title":"Pharmaceutics"},{"issue":"7023","key":"2026053110314648700_pnaf130-B6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bmj.312.7023.71","article-title":"Evidence based medicine: what it is and what it isn\u2019t","volume":"312","author":"Sackett","year":"1996","journal-title":"BMJ"},{"issue":"5","key":"2026053110314648700_pnaf130-B7","doi-asserted-by":"publisher","first-page":"CD008609","DOI":"10.1002\/14651858.CD008609.pub2","article-title":"Topical analgesics for acute and chronic pain in adults\u2014an overview of Cochrane Reviews","volume":"5","author":"Derry","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2026053110314648700_pnaf130-B8","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/s1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol"},{"issue":"2","key":"2026053110314648700_pnaf130-B9","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1213\/ane.0000000000001998","article-title":"Interventions for neuropathic pain: an overview of systematic reviews","volume":"125","author":"Dosenovic","year":"2017","journal-title":"Anesth Analg"},{"issue":"6","key":"2026053110314648700_pnaf130-B10","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2217\/pmt-2017-0020","article-title":"Management of chronic neuropathic pain with single and compounded topical analgesics","volume":"7","author":"Knezevic","year":"2017","journal-title":"Pain Manag"},{"key":"2026053110314648700_pnaf130-B11","author":"ZTlido FDA Approval History"},{"key":"2026053110314648700_pnaf130-B12","author":"U.S. Preventive Services Task Force Grade Definitions"},{"issue":"2","key":"2026053110314648700_pnaf130-B13","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/ner.12538","article-title":"The Polyanalgesic Consensus Conference (PACC): recommendations on intrathecal drug infusion systems best practices and guidelines","volume":"20","author":"Deer","year":"2017","journal-title":"Neuromodulation"},{"key":"2026053110314648700_pnaf130-B14","doi-asserted-by":"publisher","first-page":"998904","DOI":"10.3389\/fneur.2022.998904","article-title":"Reversing painful and non-painful diabetic neuropathy with the capsaicin 8% patch: clinical evidence for pain relief and restoration of function via nerve fiber regeneration","volume":"13","author":"Anand","year":"2022","journal-title":"Front Neurol"},{"issue":"2","key":"2026053110314648700_pnaf130-B15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/s0168-3659(98)00187-4","article-title":"Chemical enhancement of percutaneous absorption in relation to stratum corneum structural alterations","volume":"59","author":"Marjukka Suhonen","year":"1999","journal-title":"J Control Release"},{"issue":"12","key":"2026053110314648700_pnaf130-B16","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/s1474-4422(08)70228-x","article-title":"NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study","volume":"7","author":"Backonja","year":"2008","journal-title":"Lancet Neurol"},{"issue":"1","key":"2026053110314648700_pnaf130-B17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1526-4637.2010.01004.x","article-title":"A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia","volume":"12","author":"Irving","year":"2011","journal-title":"Pain Med"},{"issue":"10","key":"2026053110314648700_pnaf130-B18","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.jpain.2010.01.270","article-title":"A multicenter, randomized, double-blind, controlled dose finding study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia","volume":"11","author":"Webster","year":"2010","journal-title":"J Pain"},{"key":"2026053110314648700_pnaf130-B19","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1471-2377-10-92","article-title":"Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgia","volume":"10","author":"Webster","year":"2010","journal-title":"BMC Neurol"},{"issue":"1","key":"2026053110314648700_pnaf130-B20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jpain.2016.09.008","article-title":"Capsaicin 8% patch in painful diabetic peripheral neuropathy: a randomized, double-blind, placebo-controlled study","volume":"18","author":"Simpson","year":"2017","journal-title":"J Pain"},{"issue":"1","key":"2026053110314648700_pnaf130-B21","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12883-016-0752-7","article-title":"Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study","volume":"16","author":"Vinik","year":"2016","journal-title":"BMC Neurol"},{"issue":"2","key":"2026053110314648700_pnaf130-B22","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.diabres.2011.04.010","article-title":"Efficacy, safety, and tolerability of NGX-4010, capsaicin 8% patch, in an open-label study of patients with peripheral neuropathic pain","volume":"93","author":"Webster","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"2026053110314648700_pnaf130-B23","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/QAI.0b013e31823e31f7","article-title":"A randomized, double-blind, controlled study of NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy","volume":"59","author":"Clifford","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"2026053110314648700_pnaf130-B24","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jpainsymman.2007.04.015","article-title":"An open-label pilot study of high-concentration capsaicin patch in painful HIV neuropathy","volume":"35","author":"Simpson","year":"2008","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"2026053110314648700_pnaf130-B25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1742-6405-10-5","article-title":"NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trials","volume":"10","author":"Brown","year":"2013","journal-title":"AIDS Res Ther"},{"issue":"2","key":"2026053110314648700_pnaf130-B26","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/AJP.0b013e318287a32f","article-title":"NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: results of a 52-week open-label study","volume":"30","author":"Simpson","year":"2014","journal-title":"Clin J Pain"},{"issue":"10","key":"2026053110314648700_pnaf130-B27","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1097\/AJP.0000000000000473","article-title":"Capsaicin 8% patch repeat treatment in nondiabetic peripheral neuropathic pain: a 52-week, open-label, single-arm, safety study","volume":"33","author":"G\u00e1lvez","year":"2017","journal-title":"Clin J Pain"},{"issue":"10","key":"2026053110314648700_pnaf130-B28","doi-asserted-by":"publisher","first-page":"e109144","DOI":"10.1371\/journal.pone.0109144","article-title":"A capsaicin (8%) patch in the treatment of severe persistent inguinal postherniorrhaphy pain: a randomized, double-blind, placebo-controlled trial","volume":"9","author":"Bischoff","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"2026053110314648700_pnaf130-B29","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/ejp.731","article-title":"Capsaicin 8% patch versus oral pregabalin in patients with peripheral neuropathic pain","volume":"20","author":"Haanp\u00e4\u00e4","year":"2016","journal-title":"Eur J Pain"},{"issue":"4","key":"2026053110314648700_pnaf130-B30","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/ejp.1155","article-title":"Superiority of capsaicin 8% patch versus oral pregabalin on dynamic mechanical allodynia in patients with peripheral neuropathic pain","volume":"22","author":"Cruccu","year":"2018","journal-title":"Eur J Pain"},{"issue":"6","key":"2026053110314648700_pnaf130-B31","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1185\/03007995.2013.792246","article-title":"Prospective, non-interventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain: first results of the QUEPP study","volume":"29","author":"Maihofner","year":"2013","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"2026053110314648700_pnaf130-B32","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1185\/03007995.2013.869491","article-title":"High concentration capsaicin for treatment of peripheral neuropathic pain: effect on somatosensory symptoms and identification of treatment responders","volume":"30","author":"H\u00f6per","year":"2014","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"2026053110314648700_pnaf130-B33","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12883-017-0836-z","article-title":"Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study","volume":"17","author":"Mankowski","year":"2017","journal-title":"BMC Neurol"},{"issue":"5","key":"2026053110314648700_pnaf130-B34","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1002\/ejp.1180","article-title":"Pain-relieving effectiveness, quality of life and tolerability of repeated capsaicin 8% patch treatment of peripheral neuropathic pain in Scandinavian clinical practice","volume":"22","author":"Hansson","year":"2018","journal-title":"Eur J Pain"},{"issue":"9","key":"2026053110314648700_pnaf130-B35","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s12032-017-1015-1","article-title":"High-dose 8% capsaicin patch in treatment of chemotherapy-induced peripheral neuropathy: single-center experience","volume":"34","author":"Filipczak-Bryniarska","year":"2017","journal-title":"Med Oncol"},{"key":"2026053110314648700_pnaf130-B36","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.2147\/jpr.S213912","article-title":"Rational treatment of chemotherapy-induced peripheral neuropathy with capsaicin 8% patch: from pain relief towards disease modification","volume":"12","author":"Anand","year":"2019","journal-title":"J Pain Res"},{"key":"2026053110314648700_pnaf130-B37","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1200\/jco.2016.34.26_suppl.208","article-title":"Investigating high-concentration 8% capsaicin patch in chronic cancer-treatment related peripheral neuropathic pain","volume":"34(26_suppl)","author":"Ramnarine","year":"2016","journal-title":"J Clin Oncol"},{"issue":"15_suppl","key":"2026053110314648700_pnaf130-B38","doi-asserted-by":"publisher","first-page":"e14031","DOI":"10.1200\/JCO.2016.34.15_suppl.e14031","article-title":"Improvement of chemotherapy induced neuropathy (CIN) in cancer patients using capsaicin 8% patch","volume":"34","author":"Marec","year":"2016","journal-title":"J Clin Oncol"},{"issue":"3","key":"2026053110314648700_pnaf130-B39","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/00000539-199803000-00027","article-title":"Treatment of intractable pain with topical large-dose capsaicin: preliminary report","volume":"86","author":"Robbins","year":"1998","journal-title":"Anesth Analg"},{"issue":"24","key":"2026053110314648700_pnaf130-B40","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1212\/01.wnl.0000314647.35825.9c","article-title":"Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy","volume":"70","author":"Simpson","year":"2008","journal-title":"Neurology"},{"issue":"1","key":"2026053110314648700_pnaf130-B41","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/AJP.0b013e318156db26","article-title":"Topical amitriptyline versus lidocaine in the treatment of neuropathic pain","volume":"24","author":"Ho","year":"2008","journal-title":"Clin J Pain"},{"issue":"7","key":"2026053110314648700_pnaf130-B42","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1185\/03007990903047880","article-title":"5% Lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study","volume":"25","author":"Baron","year":"2009","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"2026053110314648700_pnaf130-B43","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0304-3959(95)00146-8","article-title":"Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia","volume":"65","author":"Rowbotham","year":"1996","journal-title":"Pain"},{"issue":"3","key":"2026053110314648700_pnaf130-B44","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/s0304-3959(98)00244-9","article-title":"Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study","volume":"80","author":"Galer","year":"1999","journal-title":"Pain"},{"issue":"5","key":"2026053110314648700_pnaf130-B45","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/00002508-200209000-00004","article-title":"The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the Neuropathic Pain Scale","volume":"18","author":"Galer","year":"2002","journal-title":"Clin J Pain"},{"issue":"7","key":"2026053110314648700_pnaf130-B46","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s13555-023-00938-8","article-title":"Randomized, placebo-controlled, multicenter clinical study on the efficacy and safety of lidocaine patches in Chinese patients with postherpetic neuralgia","volume":"13","author":"Wang","year":"2023","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"6","key":"2026053110314648700_pnaf130-B47","doi-asserted-by":"publisher","first-page":"393","DOI":"10.2165\/00044011-200929060-00003","article-title":"Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trial","volume":"29","author":"Binder","year":"2009","journal-title":"Clin Drug Investig"},{"issue":"4","key":"2026053110314648700_pnaf130-B48","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1046\/j.1526-4637.2002.02050.x","article-title":"Lidocaine patch 5% reduces pain intensity and interference with quality of life in patients with postherpetic neuralgia: an effectiveness trial","volume":"3","author":"Katz","year":"2002","journal-title":"Pain Med"},{"issue":"5","key":"2026053110314648700_pnaf130-B49","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1001\/archinte.163.5.628","article-title":"More than 7 years of consistent neuropathic pain relief in geriatric patients","volume":"163","author":"Galer","year":"2003","journal-title":"Arch Intern Med"},{"issue":"9","key":"2026053110314648700_pnaf130-B50","doi-asserted-by":"publisher","first-page":"693","DOI":"10.2165\/11595600-000000000-00000","article-title":"5% Lidocaine medicated plaster in elderly patients with postherpetic neuralgia: results of a compassionate use programme in France","volume":"28","author":"Cl\u00e8re","year":"2011","journal-title":"Drugs Aging"},{"issue":"1","key":"2026053110314648700_pnaf130-B51","doi-asserted-by":"publisher","first-page":"e14590","DOI":"10.1111\/dth.14590","article-title":"Effectiveness and safety of lidocaine patch 5% to treat herpes zoster acute neuralgia and to prevent postherpetic neuralgia","volume":"34","author":"Bianchi","year":"2021","journal-title":"Dermatol Ther"},{"key":"2026053110314648700_pnaf130-B52","doi-asserted-by":"publisher","first-page":"551","DOI":"10.2147\/ppa.S42643","article-title":"Influence of anatomic location of lidocaine patch 5% on effectiveness and tolerability for postherpetic neuralgia","volume":"7","author":"Nalamachu","year":"2013","journal-title":"Patient Prefer Adherence"},{"issue":"3","key":"2026053110314648700_pnaf130-B53","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2217\/pmt-2015-0010","article-title":"Impact of topical 5% lidocaine-medicated plasters on sleep and quality of life in patients with postherpetic neuralgia","volume":"6","author":"Binder","year":"2016","journal-title":"Pain Manag"},{"issue":"6","key":"2026053110314648700_pnaf130-B54","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1001\/archneur.61.6.914","article-title":"Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy","volume":"61","author":"Barbano","year":"2004","journal-title":"Arch Neurol"},{"issue":"5","key":"2026053110314648700_pnaf130-B55","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1097\/j.pain.0000000000001502","article-title":"Effectiveness and safety of 5% lidocaine-medicated plaster on localized neuropathic pain after knee surgery: a randomized, double-blind controlled trial","volume":"160","author":"Pickering","year":"2019","journal-title":"Pain"},{"issue":"6","key":"2026053110314648700_pnaf130-B56","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1097\/ALN.0b013e3182a2a243","article-title":"Lidocaine patch (5%) in treatment of persistent inguinal postherniorrhaphy pain: a randomized, double-blind, placebo-controlled, crossover trial","volume":"119","author":"Bischoff","year":"2013","journal-title":"Anesthesiology"},{"issue":"5","key":"2026053110314648700_pnaf130-B57","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1080\/03007995.2019.1565709","article-title":"Lidocaine medicated plaster, an additional potential treatment option for localized post-surgical neuropathic pain: efficacy and safety results of a randomized, placebo-controlled trial","volume":"35","author":"Palladini","year":"2019","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"2026053110314648700_pnaf130-B58","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00520-008-0542-x","article-title":"Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: a phase III double-blind crossover study (N01CB)","volume":"17","author":"Cheville","year":"2009","journal-title":"Support Care Cancer"},{"issue":"5","key":"2026053110314648700_pnaf130-B59","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1055\/s-0041-1735911","article-title":"Application of 5% lidocaine adhesive patch in painful surgical scars: clinical trial","volume":"56","author":"Macedo","year":"2021","journal-title":"Rev Bras Ortop (Sao Paulo)"},{"issue":"3","key":"2026053110314648700_pnaf130-B60","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2217\/pmt-2016-0060","article-title":"Efficacy of the topical 5% lidocaine medicated plaster in the treatment of chronic post-thoracotomy neuropathic pain","volume":"7","author":"Sansone","year":"2017","journal-title":"Pain Manag"},{"issue":"4","key":"2026053110314648700_pnaf130-B61","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1053\/rapm.2000.7812","article-title":"EMLA reduces acute and chronic pain after breast surgery for cancer","volume":"25","author":"Fassoulaki","year":"2000","journal-title":"Reg Anesth Pain Med"},{"issue":"11","key":"2026053110314648700_pnaf130-B62","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1185\/03007990903282297","article-title":"Management of neuropathic pain after surgical and non-surgical trauma with lidocaine 5% patches: study of 40 consecutive cases","volume":"25","author":"Hans","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"2026053110314648700_pnaf130-B63","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2147\/lra.S31868","article-title":"Use of 5% lidocaine medicated plaster to treat localized neuropathic pain secondary to traumatic injury of peripheral nerves","volume":"5","author":"Correa-Illanes","year":"2012","journal-title":"Local Reg Anesth"},{"key":"2026053110314648700_pnaf130-B64","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2147\/lra.S13082","article-title":"Treatment of localized post-traumatic neuropathic pain in scars with 5% lidocaine medicated plaster","volume":"3","author":"Correa-Illanes","year":"2010","journal-title":"Local Reg Anesth"},{"issue":"5","key":"2026053110314648700_pnaf130-B65","doi-asserted-by":"publisher","first-page":"3331024231168086","DOI":"10.1177\/03331024231168086","article-title":"Lidocaine aerosol sprayed on oral and\/or nasal mucosa for the rescue of acute trigeminal neuralgia exacerbations: a retrospective study","volume":"43","author":"Zhou","year":"2023","journal-title":"Cephalalgia"},{"issue":"5","key":"2026053110314648700_pnaf130-B66","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1177\/10600280221120457","article-title":"Effectiveness, safety, and predictors of response to 5% lidocaine-medicated plaster for the treatment of patients with trigeminal neuralgia: a retrospective study","volume":"57","author":"Yu","year":"2023","journal-title":"Ann Pharmacother"},{"issue":"2","key":"2026053110314648700_pnaf130-B67","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1177\/2049463713483459","article-title":"Case studies illustrating the management of trigeminal neuropathic pain using topical 5% lidocaine plasters","volume":"7","author":"Khawaja","year":"2013","journal-title":"Br J Pain"},{"issue":"5","key":"2026053110314648700_pnaf130-B68","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.ijom.2011.11.002","article-title":"Managing iatrogenic trigeminal nerve injury: a case series and review of the literature","volume":"41","author":"Renton","year":"2012","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"5","key":"2026053110314648700_pnaf130-B69","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1097\/00126334-200412150-00010","article-title":"A randomized controlled trial of 5% lidocaine gel for HIV-associated distal symmetric polyneuropathy","volume":"37","author":"Estanislao","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"2026053110314648700_pnaf130-B70","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1526-4637.2005.00058.x","article-title":"An open-label study of the lidocaine patch 5% in painful idiopathic sensory polyneuropathy","volume":"6","author":"Herrmann","year":"2005","journal-title":"Pain Med"},{"key":"2026053110314648700_pnaf130-B71","doi-asserted-by":"publisher","first-page":"763","DOI":"10.2147\/jpr.S113517","article-title":"5% Lidocaine-medicated plaster for the treatment of chronic peripheral neuropathic pain: complex regional pain syndrome and other neuropathic conditions","volume":"9","author":"Calder\u00f3n","year":"2016","journal-title":"J Pain Res"},{"issue":"1\u20132","key":"2026053110314648700_pnaf130-B72","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/s0304-3959(03)00317-8","article-title":"Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study","volume":"106","author":"Meier","year":"2003","journal-title":"Pain"},{"issue":"12","key":"2026053110314648700_pnaf130-B73","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1097\/00002030-199908200-00025","article-title":"Treatment of painful distal sensory polyneuropathy in HIV-infected patients with a topical agent: results of an open-label trial of 5% lidocaine gel","volume":"13","author":"Dorfman","year":"1999","journal-title":"AIDS"},{"issue":"2","key":"2026053110314648700_pnaf130-B74","doi-asserted-by":"publisher","first-page":"162","DOI":"10.5021\/ad.2011.23.2.162","article-title":"Efficacy of piroxicam patch compared to lidocaine patch for the treatment of postherpetic neuralgia","volume":"23","author":"Kim","year":"2011","journal-title":"Ann Dermatol"},{"issue":"1","key":"2026053110314648700_pnaf130-B75","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/aln.0000000000000693","article-title":"Effect of 1.5% topical diclofenac on clinical neuropathic pain","volume":"123","author":"Ahmed","year":"2015","journal-title":"Anesthesiology"},{"issue":"2","key":"2026053110314648700_pnaf130-B76","first-page":"103","article-title":"Topical acetylsalicylic acid versus lidocaine for postherpetic neuralgia: results of a double-blind comparative clinical trial","volume":"7","author":"Tajti","year":"1999","journal-title":"Neurobiology (Bp)"},{"issue":"3","key":"2026053110314648700_pnaf130-B77","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s002280050451","article-title":"Skin and plasma levels of acetylsalicylic acid: a comparison between topical aspirin\/diethyl ether mixture and oral aspirin in acute herpes zoster and postherpetic neuralgia","volume":"54","author":"Bareggi","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"2026053110314648700_pnaf130-B78","first-page":"337","article-title":"Herpes zoster and post-herpetic neuralgia\u2014a clinical trial of aspirin in chloroform for anodyne","volume":"46","author":"Kochar","year":"1998","journal-title":"J Assoc Physicians India"},{"issue":"1","key":"2026053110314648700_pnaf130-B79","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0304-3959(95)00155-7","article-title":"Topical aspirin\/diethyl ether mixture versus indomethacin and diclofenac\/diethyl ether mixtures for acute herpetic neuralgia and postherpetic neuralgia: a double-blind crossover placebo-controlled study","volume":"65","author":"De Benedittis","year":"1996","journal-title":"Pain"},{"issue":"10","key":"2026053110314648700_pnaf130-B80","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1001\/archneur.1993.00540100041012","article-title":"Topical aspirin in chloroform and the relief of pain due to herpes zoster and postherpetic neuralgia","volume":"50","author":"King","year":"1993","journal-title":"Arch Neurol"},{"issue":"3","key":"2026053110314648700_pnaf130-B81","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0304-3959(92)90088-S","article-title":"A new topical treatment for acute herpetic neuralgia and post-herpetic neuralgia: the aspirin\/diethyl ether mixture. An open-label study plus a double-blind controlled clinical trial","volume":"48","author":"De Benedittis","year":"1992","journal-title":"Pain"},{"issue":"6","key":"2026053110314648700_pnaf130-B82","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1111\/pme.12110","article-title":"Topical diclofenac treatment for post-incisional neuropathic pain","volume":"14","author":"Chien","year":"2013","journal-title":"Pain Med"},{"issue":"8","key":"2026053110314648700_pnaf130-B83","doi-asserted-by":"publisher","first-page":"252","DOI":"10.5489\/cuaj.4976","article-title":"Early experience with topical meloxicam and lidocaine combination for the treatment of vulvodynia","volume":"12","author":"Kim","year":"2018","journal-title":"Can Urol Assoc J"},{"issue":"6","key":"2026053110314648700_pnaf130-B84","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s00520-010-0911-0","article-title":"A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA","volume":"19","author":"Barton","year":"2011","journal-title":"Support Care Cancer"},{"issue":"7","key":"2026053110314648700_pnaf130-B85","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1007\/s00520-014-2158-7","article-title":"A phase III randomized, placebo-controlled study of topical amitriptyline and ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study of 462 cancer survivors","volume":"22","author":"Gewandter","year":"2014","journal-title":"Support Care Cancer"},{"issue":"4","key":"2026053110314648700_pnaf130-B86","first-page":"1263","article-title":"Amitriptyline 2% cream vs. capsaicin 0.75% cream in the treatment of painful diabetic neuropathy (double blind, randomized clinical trial of efficacy and safety)","volume":"14","author":"Kiani","year":"2015","journal-title":"Iran J Pharm Res. Fall"},{"issue":"1","key":"2026053110314648700_pnaf130-B87","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/00000542-200507000-00021","article-title":"Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial","volume":"103","author":"Lynch","year":"2005","journal-title":"Anesthesiology"},{"issue":"5","key":"2026053110314648700_pnaf130-B88","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/00002508-200309000-00007","article-title":"A pilot study examining topical amitriptyline, ketamine, and a combination of both in the treatment of neuropathic pain","volume":"19","author":"Lynch","year":"2003","journal-title":"Clin J Pain"},{"issue":"7","key":"2026053110314648700_pnaf130-B89","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1007\/s00520-011-1240-7","article-title":"Topical amitriptyline, ketamine, and lidocaine in neuropathic pain caused by radiation skin reaction: a pilot study","volume":"20","author":"Uzaraga","year":"2012","journal-title":"Support Care Cancer"},{"issue":"10","key":"2026053110314648700_pnaf130-B90","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.jpain.2005.04.008","article-title":"Topical amitriptyline and ketamine in neuropathic pain syndromes: an open-label study","volume":"6","author":"Lynch","year":"2005","journal-title":"J Pain"},{"issue":"2","key":"2026053110314648700_pnaf130-B91","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/ajo.13292","article-title":"Topical treatment of vulvodynia, dyspareunia and pudendal neuralgia: a single clinic audit of amitriptyline and oestriol in organogel","volume":"61","author":"Ruoss","year":"2021","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"2","key":"2026053110314648700_pnaf130-B92","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1533-2500.2011.00477.x","article-title":"High doses of topical amitriptyline in neuropathic pain: two cases and literature review","volume":"12","author":"Kopsky","year":"2012","journal-title":"Pain Pract"},{"key":"2026053110314648700_pnaf130-B93","doi-asserted-by":"publisher","first-page":"471835","DOI":"10.1155\/2012\/471835","article-title":"Central neuropathic pain in a patient with multiple sclerosis treated successfully with topical amitriptyline","volume":"2012","author":"Kopsky","year":"2012","journal-title":"Case Rep Med"},{"issue":"4","key":"2026053110314648700_pnaf130-B94","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1016\/j.jpainsymman.2011.01.003","article-title":"Topical amitriptyline in post-traumatic neuropathic pain","volume":"41","author":"Liebregts","year":"2011","journal-title":"J Pain Symptom Manage"},{"issue":"6","key":"2026053110314648700_pnaf130-B95","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1046\/j.1365-2125.2000.00200.x","article-title":"Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study","volume":"49","author":"McCleane","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"2026053110314648700_pnaf130-B96","doi-asserted-by":"publisher","first-page":"319750","DOI":"10.1155\/2011\/319750","article-title":"Multimodal stepped care approach involving topical analgesics for severe intractable neuropathic pain in CRPS type 1: a case report","volume":"2011","author":"Kopsky","year":"2011","journal-title":"Case Rep Med"},{"issue":"3","key":"2026053110314648700_pnaf130-B97","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/AOG.0b013e3181827c77","article-title":"Topical gabapentin in the treatment of localized and generalized vulvodynia","volume":"112","author":"Boardman","year":"2008","journal-title":"Obstet Gynecol"},{"key":"2026053110314648700_pnaf130-B98","doi-asserted-by":"publisher","first-page":"845","DOI":"10.2147\/jpr.S93107","article-title":"Genitofemoral neuralgia: adding to the burden of chronic vulvar pain","volume":"8","author":"Verstraelen","year":"2015","journal-title":"J Pain Res"},{"issue":"3","key":"2026053110314648700_pnaf130-B99","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1590\/s0365-05962012000300032","article-title":"Topical (S)-ketamine for pain management of postherpetic neuralgia","volume":"87","author":"de Barros","year":"2012","journal-title":"An Bras Dermatol"},{"issue":"3","key":"2026053110314648700_pnaf130-B100","doi-asserted-by":"publisher","first-page":"178","DOI":"10.7547\/1020178","article-title":"Topical ketamine cream in the treatment of painful diabetic neuropathy: a randomized, placebo-controlled, double-blind initial study","volume":"102","author":"Mahoney","year":"2012","journal-title":"J Am Podiatr Med Assoc"},{"key":"2026053110314648700_pnaf130-B101","doi-asserted-by":"publisher","first-page":"310913","DOI":"10.1155\/2014\/310913","article-title":"Acute effect of topical menthol on chronic pain in slaughterhouse workers with carpal tunnel syndrome: triple-blind, randomized placebo-controlled trial","volume":"2014","author":"Sundstrup","year":"2014","journal-title":"Rehabil Res Pract"},{"key":"2026053110314648700_pnaf130-B102","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.neulet.2012.11.005","article-title":"The effects of menthol on cold allodynia and wind-up-like pain in upper limb amputees with different levels of phantom limb pain","volume":"534","author":"Vase","year":"2013","journal-title":"Neurosci Lett"},{"issue":"9","key":"2026053110314648700_pnaf130-B103","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1007\/s00520-015-2642-8","article-title":"Cancer treatment\u2013related neuropathic pain: proof of concept study with menthol\u2014a TRPM8 agonist","volume":"23","author":"Fallon","year":"2015","journal-title":"Support Care Cancer"},{"issue":"3","key":"2026053110314648700_pnaf130-B104","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1016\/j.jpainsymman.2015.04.024","article-title":"Topical L-menthol for postradiotherapy neuropathic pain: a case report","volume":"50","author":"Brid","year":"2015","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"2026053110314648700_pnaf130-B105","doi-asserted-by":"publisher","first-page":"350","DOI":"10.4103\/IJPC.IJPC_23_17","article-title":"Topical menthol for treatment of chemotherapy-induced peripheral neuropathy","volume":"23","author":"Cortellini","year":"2017","journal-title":"Indian J Palliat Care"},{"issue":"3","key":"2026053110314648700_pnaf130-B106","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/00002508-200205000-00011","article-title":"A novel treatment of postherpetic neuralgia using peppermint oil","volume":"18","author":"Davies","year":"2002","journal-title":"Clin J Pain"},{"issue":"2","key":"2026053110314648700_pnaf130-B107","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/1753-0407.12287","article-title":"Topical Citrullus colocynthis (bitter apple) extract oil in painful diabetic neuropathy: a double-blind randomized placebo-controlled clinical trial","volume":"8","author":"Heydari","year":"2016","journal-title":"J Diabetes"},{"issue":"10","key":"2026053110314648700_pnaf130-B108","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1002\/ptr.6442","article-title":"Efficacy of topical Citrullus colocynthis (bitter apple) extract oil in chemotherapy-induced peripheral neuropathy: a pilot double-blind randomized placebo-controlled clinical trial","volume":"33","author":"Rostami","year":"2019","journal-title":"Phytother Res"},{"issue":"9","key":"2026053110314648700_pnaf130-B109","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1089\/acm.2020.0012","article-title":"Topical Costus sp. preparation as palliative care for chemotherapy-induced peripheral neuropathy of patients: a randomized placebo-controlled pilot trial","volume":"26","author":"Heydarirad","year":"2020","journal-title":"J Altern Complement Med"},{"issue":"2","key":"2026053110314648700_pnaf130-B110","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/ptr.3248","article-title":"Effect of E. laciniata (L) ointment on mild and moderate carpal tunnel syndrome: a double-blind, randomized clinical trial","volume":"25","author":"Eftekharsadat","year":"2011","journal-title":"Phytother Res"},{"issue":"4","key":"2026053110314648700_pnaf130-B111","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.jht.2017.07.004","article-title":"Effectiveness of Lavendula stoechas essential oil in treatment of mild to moderate carpal tunnel syndrome: a randomized controlled trial","volume":"31","author":"Eftekharsadat","year":"2018","journal-title":"J Hand Ther"},{"issue":"9","key":"2026053110314648700_pnaf130-B112","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1007\/s10072-016-2600-3","article-title":"Trachyspermum ammi 10% topical cream versus placebo on neuropathic pain, a randomized, double-blind, placebo-controlled trial","volume":"37","author":"Petramfar","year":"2016","journal-title":"Neurol Sci"},{"issue":"1","key":"2026053110314648700_pnaf130-B113","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/2008-2231-22-43","article-title":"Effect of Linum usitatissimum L. (linseed) oil on mild and moderate carpal tunnel syndrome: a randomized, double-blind, placebo-controlled clinical trial","volume":"22","author":"Hashempur","year":"2014","journal-title":"Daru"},{"issue":"3","key":"2026053110314648700_pnaf130-B114","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1177\/2156587216677822","article-title":"A topical gel from flax seed oil compared with hand splint in carpal tunnel syndrome: a randomized clinical trial","volume":"22","author":"Setayesh","year":"2017","journal-title":"J Evid Based Complementary Altern Med"},{"key":"2026053110314648700_pnaf130-B115","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ctcp.2016.11.010","article-title":"Efficacy of topical chamomile oil for mild and moderate carpal tunnel syndrome: a randomized double-blind placebo-controlled clinical trial","volume":"26","author":"Hashempur","year":"2017","journal-title":"Complement Ther Clin Pract"},{"issue":"4","key":"2026053110314648700_pnaf130-B116","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ctcp.2015.08.001","article-title":"A pilot randomized double-blind placebo-controlled trial on topical chamomile (Matricaria chamomilla L.) oil for severe carpal tunnel syndrome","volume":"21","author":"Hashempur","year":"2015","journal-title":"Complement Ther Clin Pract"},{"issue":"4","key":"2026053110314648700_pnaf130-B117","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1089\/acm.2012.0016","article-title":"Nutmeg extracts for painful diabetic neuropathy: a randomized, double-blind, controlled study","volume":"19","author":"Motilal","year":"2013","journal-title":"J Altern Complement Med"},{"key":"2026053110314648700_pnaf130-B118","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1472-6882-10-22","article-title":"The effect of Neuragen PN on neuropathic pain: a randomized, double blind, placebo controlled clinical trial","volume":"10","author":"Li","year":"2010","journal-title":"BMC Complement Altern Med"},{"issue":"1","key":"2026053110314648700_pnaf130-B119","doi-asserted-by":"publisher","first-page":"71","DOI":"10.25259\/ijpc_32_2023","article-title":"Exploring the effectiveness of Ajwain cream in treating taxane-induced peripheral neuropathy in cancer patients: a pilot, randomised and double-blind clinical trial","volume":"30","author":"Heydarirad","year":"2024","journal-title":"Indian J Palliat Care"},{"issue":"5","key":"2026053110314648700_pnaf130-B120","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/der.0000000000000216","article-title":"Compounded topical analgesics for chronic pain","volume":"27","author":"Cline","year":"2016","journal-title":"Dermatitis"},{"issue":"4","key":"2026053110314648700_pnaf130-B121","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/j.1532-2149.2013.00400.x","article-title":"Topical analgesics for neuropathic pain: preclinical exploration, clinical validation, future development","volume":"18","author":"Sawynok","year":"2014","journal-title":"Eur J Pain"},{"issue":"4","key":"2026053110314648700_pnaf130-B122","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s13346-021-00982-x","article-title":"Dermal delivery of amitriptyline for topical analgesia","volume":"12","author":"Kung","year":"2022","journal-title":"Drug Deliv Transl Res"},{"issue":"1","key":"2026053110314648700_pnaf130-B123","first-page":"21","article-title":"Antidepressants as analgesics: an overview of central and peripheral mechanisms of action","volume":"26","author":"Sawynok","year":"2001","journal-title":"J Psychiatry Neurosci"},{"issue":"2","key":"2026053110314648700_pnaf130-B124","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1089\/can.2022.0126","article-title":"The dark side of cannabidiol: the unanticipated social and clinical implications of synthetic \u0394(8)-THC","volume":"8","author":"Geci","year":"2023","journal-title":"Cannabis Cannabinoid Res"},{"issue":"2","key":"2026053110314648700_pnaf130-B125","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14020438","article-title":"The transdermal delivery of therapeutic cannabinoids","volume":"14","author":"Mahmoudinoodezh","year":"2022","journal-title":"Pharmaceutics"},{"key":"2026053110314648700_pnaf130-B126","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1744-8069-6-16","article-title":"Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain","volume":"6","author":"Toth","year":"2010","journal-title":"Mol Pain"},{"issue":"11","key":"2026053110314648700_pnaf130-B127","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1517\/13543784.13.11.1445","article-title":"Recent developments in transient receptor potential vanilloid receptor 1 agonist-based therapies","volume":"13","author":"Bley","year":"2004","journal-title":"Expert Opin Investig Drugs"},{"issue":"15","key":"2026053110314648700_pnaf130-B128","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.2174\/138161209788186308","article-title":"TRP channels and pain","volume":"15","author":"Cortright","year":"2009","journal-title":"Curr Pharm Des"},{"issue":"1\u20132","key":"2026053110314648700_pnaf130-B129","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.drudis.2008.11.005","article-title":"Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway","volume":"14","author":"Gunthorpe","year":"2009","journal-title":"Drug Discov Today"},{"issue":"6","key":"2026053110314648700_pnaf130-B130","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.jpain.2009.09.019","article-title":"A randomized, controlled, open-label study of the long-term effects of NGX-4010, a high-concentration capsaicin patch, on epidermal nerve fiber density and sensory function in healthy volunteers","volume":"11","author":"Kennedy","year":"2010","journal-title":"J Pain"},{"issue":"3","key":"2026053110314648700_pnaf130-B131","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/jcpt.12679","article-title":"The role and mechanism of action of menthol in topical analgesic products","volume":"43","author":"Pergolizzi","year":"2018","journal-title":"J Clin Pharm Ther"},{"issue":"4","key":"2026053110314648700_pnaf130-B132","doi-asserted-by":"publisher","DOI":"10.3390\/medicina54040051","article-title":"Topical anti-inflammatory and analgesic activities of Citrullus colocynthis extract cream in rats","volume":"54","author":"Pashmforosh","year":"2018","journal-title":"Medicina (Kaunas)"},{"issue":"04","key":"2026053110314648700_pnaf130-B133","doi-asserted-by":"publisher","first-page":"147","DOI":"10.4172\/2168-9547.1000147","article-title":"The effect of Citrullus colocynthis on the reduction of inflammatory agents in osteoarthritis","volume":"04","author":"Akhzari","year":"2015","journal-title":"Mol Biol"},{"issue":"23","key":"2026053110314648700_pnaf130-B134","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4103\/phrev.phrev_29_17","article-title":"Costus speciosus: traditional uses, phytochemistry, and therapeutic potentials","volume":"12","author":"El-Far","year":"2018","journal-title":"Phcog Rev"},{"issue":"1","key":"2026053110314648700_pnaf130-B135","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18311\/jnr\/2009\/213","article-title":"Evaluation of analgesic activity of Eremostachys laciniata in mice","volume":"9","author":"Delazar","year":"2009","journal-title":"J Nat Remed"},{"issue":"10","key":"2026053110314648700_pnaf130-B136","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3109\/13880200903517950","article-title":"Anti-inflammatory study of crude methanol extract and different fractions of Eremostachys laciniata","volume":"48","author":"Khan","year":"2010","journal-title":"Pharm Biol"},{"key":"2026053110314648700_pnaf130-B137","doi-asserted-by":"publisher","first-page":"681304","DOI":"10.1155\/2013\/681304","article-title":"Lavender and the nervous system","volume":"2013","author":"Koulivand","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"2026053110314648700_pnaf130-B138","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s12906-021-03461-5","article-title":"Anti-inflammatory effect of lavender (Lavandula angustifolia Mill.) essential oil prepared during different plant phenophases on THP-1 macrophages","volume":"21","author":"Pandur","year":"2021","journal-title":"BMC Complement Med Ther"},{"issue":"4","key":"2026053110314648700_pnaf130-B139","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1142\/S0192415X12500632","article-title":"Effect of lavender essential oil on LPS-stimulated inflammation","volume":"40","author":"Huang","year":"2012","journal-title":"Am J Chin Med"},{"issue":"1","key":"2026053110314648700_pnaf130-B140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.11648\/j.pst.20210501.11","article-title":"An overview on ajwain (Trachyspermum ammi) pharmacological effects: current and conventional","volume":"5","author":"Hanif","year":"2021","journal-title":"Pharm Sci Technol"},{"issue":"2","key":"2026053110314648700_pnaf130-B141","first-page":"44","article-title":"Antinociceptive activity of the alcoholic extract of Trachyspermum ammi (L.) (ajwain) in rats","volume":"1","author":"Al-Khazraji","year":"2017","journal-title":"SIOSS J Sport Sci"},{"issue":"11","key":"2026053110314648700_pnaf130-B142","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4103\/0973-7847.95871","article-title":"Trachyspermum ammi","volume":"6","author":"Bairwa","year":"2012","journal-title":"Pharmacogn Rev"},{"issue":"59","key":"2026053110314648700_pnaf130-B143","first-page":"18466","article-title":"An overview of ajwain (Trachyspermum anni)","volume":"10","author":"Panda","year":"2020","journal-title":"Indian J Nat Sci"},{"issue":"12","key":"2026053110314648700_pnaf130-B144","first-page":"932","article-title":"Anti-inflammatory, analgesic and antipyretic activities of Linum usitatissimum L. (flaxseed\/linseed) fixed oil","volume":"49","author":"Kaithwas","year":"2011","journal-title":"Indian J Exp Biol"},{"issue":"4","key":"2026053110314648700_pnaf130-B145","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1177\/2156587217717416","article-title":"The analgesic and anti-inflammatory activity of Linum usitatissimum in Balb\/c mice","volume":"22","author":"Rafieian-Kopaei","year":"2017","journal-title":"J Evid Based Complementary Altern Med"},{"issue":"19\u201320","key":"2026053110314648700_pnaf130-B146","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.lfs.2009.09.007","article-title":"Chamomile, a novel and selective COX-2 inhibitor with anti-inflammatory activity","volume":"85","author":"Srivastava","year":"2009","journal-title":"Life Sci"},{"key":"2026053110314648700_pnaf130-B147","doi-asserted-by":"publisher","first-page":"30849","DOI":"10.3402\/fnr.v60.30849","article-title":"Nutmeg oil alleviates chronic inflammatory pain through inhibition of COX-2 expression and substance P release in vivo","volume":"60","author":"Zhang","year":"2016","journal-title":"Food Nutr Res"},{"key":"2026053110314648700_pnaf130-B148","doi-asserted-by":"publisher","first-page":"111219","DOI":"10.1016\/j.jclinane.2023.111219","article-title":"Effect and safety profile of topical lidocaine on post-surgical neuropathic pain and quality of life: a systematic review and meta-analysis","volume":"92","author":"Mao","year":"2024","journal-title":"J Clin Anesth"},{"issue":"2","key":"2026053110314648700_pnaf130-B149","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.pain.2011.08.020","article-title":"Lidocaine patch (5%) produces a selective, but incomplete block of A\u03b4 and C fibers","volume":"153","author":"Krumova","year":"2012","journal-title":"Pain"},{"key":"2026053110314648700_pnaf130-B150","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2147\/tcrm.S58844","article-title":"Building a diagnostic algorithm on localized neuropathic pain (LNP) and targeted topical treatment: focus on 5% lidocaine-medicated plaster","volume":"10","author":"Casale","year":"2014","journal-title":"Ther Clin Risk Manag"},{"issue":"2","key":"2026053110314648700_pnaf130-B151","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s40122-016-0060-3","article-title":"The 5% lidocaine-medicated plaster: its inclusion in international treatment guidelines for treating localized neuropathic pain, and clinical evidence supporting its use","volume":"5","author":"Baron","year":"2016","journal-title":"Pain Ther"},{"issue":"3","key":"2026053110314648700_pnaf130-B152","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1067\/mai.2002.122155","article-title":"Inhibitory effect of lidocaine on T cells from patients with allergic asthma","volume":"109","author":"Tanaka","year":"2002","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"2026053110314648700_pnaf130-B153","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2174\/1874467210801030255","article-title":"TRPV1: on the road to pain relief","volume":"1","author":"Jara-Oseguera","year":"2008","journal-title":"Curr Mol Pharmacol"},{"key":"2026053110314648700_pnaf130-B154","doi-asserted-by":"publisher","first-page":"790524","DOI":"10.3389\/fpain.2021.790524","article-title":"Keratinocyte biomarkers distinguish painful diabetic peripheral neuropathy patients and correlate with topical lidocaine responsiveness","volume":"2","author":"Albrecht","year":"2021","journal-title":"Front Pain Res (Lausanne)"},{"issue":"1\u20132","key":"2026053110314648700_pnaf130-B155","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.pain.2006.09.014","article-title":"Brain activity for spontaneous pain of postherpetic neuralgia and its modulation by lidocaine patch therapy","volume":"128","author":"Geha","year":"2007","journal-title":"Pain"},{"issue":"4","key":"2026053110314648700_pnaf130-B156","first-page":"440","article-title":"Analgesic effects of topical ketamine","volume":"81","author":"Kopsky","year":"2015","journal-title":"Minerva Anestesiol"},{"issue":"8","key":"2026053110314648700_pnaf130-B157","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1089\/jpm.2012.9571","article-title":"Topical capsaicin for neuropathic pain #255","volume":"15","author":"Groninger","year":"2012","journal-title":"J Palliat Med"},{"issue":"5","key":"2026053110314648700_pnaf130-B158","doi-asserted-by":"publisher","first-page":"534","DOI":"10.2174\/1389201024666230714143538","article-title":"Medicinal plants for the treatment of neuropathic pain: a review of randomized controlled trials","volume":"25","author":"Ahmadzade","year":"2024","journal-title":"Curr Pharm Biotechnol"},{"issue":"5","key":"2026053110314648700_pnaf130-B159","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.jaad.2007.04.008","article-title":"Menthol: a refreshing look at this ancient compound","volume":"57","author":"Patel","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"2026053110314648700_pnaf130-B160","doi-asserted-by":"publisher","first-page":"CD007393","DOI":"10.1002\/14651858.CD007393.pub4","article-title":"Topical capsaicin (high concentration) for chronic neuropathic pain in adults","volume":"1","author":"Derry","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"2026053110314648700_pnaf130-B161","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1093\/pm\/pnab113","article-title":"Progressive response to repeat application of capsaicin 179 mg (8% w\/w) cutaneous patch in peripheral neuropathic pain: comprehensive new analysis and clinical implications","volume":"22","author":"Freynhagen","year":"2021","journal-title":"Pain Med"},{"key":"2026053110314648700_pnaf130-B162","author":"Qutenza Alternatives Compared"},{"issue":"3","key":"2026053110314648700_pnaf130-B163","doi-asserted-by":"publisher","first-page":"e0150973","DOI":"10.1371\/journal.pone.0150973","article-title":"Cost-effectiveness of capsaicin 8% patch compared with pregabalin for the treatment of patients with peripheral neuropathic pain in Scotland","volume":"11","author":"Mankowski","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"2026053110314648700_pnaf130-B164","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1185\/03007995.2011.562885","article-title":"Cost-effectiveness analysis of a new 8% capsaicin patch compared to existing therapies for postherpetic neuralgia","volume":"27","author":"Armstrong","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"2026053110314648700_pnaf130-B165","volume-title":"Capsaicin for Acute or Chronic Non-Cancer Pain: A Review of Clinical Effectiveness, Safety, and Cost-Effectiveness","author":"Banerjee","year":"2020"},{"issue":"12","key":"2026053110314648700_pnaf130-B166","doi-asserted-by":"publisher","first-page":"S555","DOI":"10.1016\/j.jval.2023.09.2979","article-title":"Clinical benefits and cost-effectiveness of high-dose capsaicin cutaneous patches for peripheral neuropathic pain: a literature review","volume":"26","author":"Schubert","year":"2023","journal-title":"JAMA Neurol"},{"issue":"7","key":"2026053110314648700_pnaf130-B167","doi-asserted-by":"publisher","first-page":"CD010958","DOI":"10.1002\/14651858.CD010958.pub2","article-title":"Topical lidocaine for neuropathic pain in adults","volume":"2014","author":"Derry","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"2026053110314648700_pnaf130-B168","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1600-0404.2010.01433.x","article-title":"5% lidocaine-medicated plaster vs other relevant interventions and placebo for post-herpetic neuralgia (PHN): a systematic review","volume":"123","author":"Wolff","year":"2011","journal-title":"Acta Neurol Scand"},{"issue":"21\u201322","key":"2026053110314648700_pnaf130-B169","doi-asserted-by":"publisher","first-page":"297","DOI":"10.4414\/smw.2010.12995","article-title":"5% Lidocaine medicated plaster in painful diabetic peripheral neuropathy (DPN): a systematic review","volume":"140","author":"Wolff","year":"2010","journal-title":"Swiss Med Wkly"},{"key":"2026053110314648700_pnaf130-B170","doi-asserted-by":"publisher","first-page":"110918","DOI":"10.1016\/j.jclinane.2022.110918","article-title":"The effect of lidocaine patch for postoperative pain: a meta-analysis of randomized controlled trials","volume":"81","author":"Koo","year":"2022","journal-title":"J Clin Anesth"},{"issue":"5","key":"2026053110314648700_pnaf130-B171","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/jps.10133","article-title":"Systemic absorption of topical lidocaine in normal volunteers, patients with post-herpetic neuralgia, and patients with acute herpes zoster","volume":"91","author":"Campbell","year":"2002","journal-title":"J Pharm Sci"},{"issue":"22","key":"2026053110314648700_pnaf130-B172","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1093\/ajhp\/59.22.2215","article-title":"Pharmacokinetics and safety of continuously applied lidocaine patches 5%","volume":"59","author":"Gammaitoni","year":"2002","journal-title":"Am J Health Syst Pharm"},{"key":"2026053110314648700_pnaf130-B173","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.2147\/jpr.S237934","article-title":"A randomized, open-label, bioequivalence study of lidocaine topical system 1.8% and lidocaine patch 5% in healthy subjects","volume":"13","author":"Gudin","year":"2020","journal-title":"J Pain Res"},{"key":"2026053110314648700_pnaf130-B174","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2147\/jpr.S65398","article-title":"Reduction of painful area as new possible therapeutic target in post-herpetic neuropathic pain treated with 5% lidocaine medicated plaster: a case series","volume":"7","author":"Casale","year":"2014","journal-title":"J Pain Res"},{"issue":"9","key":"2026053110314648700_pnaf130-B175","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","article-title":"EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision","volume":"17","author":"Attal","year":"2010","journal-title":"Eur J Neurol"},{"key":"2026053110314648700_pnaf130-B176","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/jpr.S15534","article-title":"Outcome predictors for treatment success with 5% lidocaine medicated plaster in low back pain with neuropathic components and neuropathic pain after surgical and nonsurgical trauma","volume":"4","author":"Nicolaou","year":"2011","journal-title":"J Pain Res"},{"key":"2026053110314648700_pnaf130-B177","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2147\/jpr.S287153","article-title":"Open-label adhesion performance studies of a new lidocaine topical system 1.8% versus lidocaine patches 5% and lidocaine medicated plaster 5% in healthy subjects","volume":"14","author":"Gudin","year":"2021","journal-title":"J Pain Res"},{"key":"2026053110314648700_pnaf130-B178","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.2147\/jpr.S238268","article-title":"A randomized, crossover, pharmacokinetic and adhesion performance study of a lidocaine topical system 1.8% during physical activity and heat treatment in healthy subjects","volume":"13","author":"Fudin","year":"2020","journal-title":"J Pain Res"},{"issue":"4","key":"2026053110314648700_pnaf130-B179","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/DAD.0b013e3182a27b83","article-title":"Immunohistochemical evaluation of COX-1 and COX-2 expression in keloid and hypertrophic scar","volume":"36","author":"Abdou","year":"2014","journal-title":"Am J Dermatopathol"},{"issue":"4","key":"2026053110314648700_pnaf130-B180","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/jid.2013.425","article-title":"The expression of proinflammatory genes in epidermal keratinocytes is regulated by hydration status","volume":"134","author":"Xu","year":"2014","journal-title":"J Invest Dermatol"},{"issue":"6","key":"2026053110314648700_pnaf130-B181","first-page":"541","article-title":"The treatment of topical drugs for postherpetic neuralgia: a network meta-analysis","volume":"23","author":"Liu","year":"2020","journal-title":"Pain Physician"},{"issue":"8","key":"2026053110314648700_pnaf130-B182","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1046\/j.1365-4362.2001.01265.x","article-title":"A randomized parallel trial of topical aspirin-moisturizer solution vs. oral aspirin for acute herpetic neuralgia","volume":"40","author":"Balakrishnan","year":"2001","journal-title":"Int J Dermatol"},{"issue":"2","key":"2026053110314648700_pnaf130-B183","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/s0304-3959(97)00049-3","article-title":"A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes","volume":"73","author":"Kingery","year":"1997","journal-title":"Pain"},{"issue":"4","key":"2026053110314648700_pnaf130-B184","doi-asserted-by":"publisher","first-page":"Cd010528","DOI":"10.1002\/14651858.CD010528.pub4","article-title":"Herbal medicinal products or preparations for neuropathic pain","volume":"4","author":"Boyd","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"2026053110314648700_pnaf130-B185","doi-asserted-by":"publisher","first-page":"390","DOI":"10.2340\/00015555-0288","article-title":"Serotonergic mechanisms in human allergic contact dermatitis","volume":"87","author":"El-Nour","year":"2007","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"2026053110314648700_pnaf130-B186","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/jcpt.12297","article-title":"Systematic review of topical amitriptyline for the treatment of neuropathic pain","volume":"40","author":"Thompson","year":"2015","journal-title":"J Clin Pharm Ther"},{"issue":"4","key":"2026053110314648700_pnaf130-B187","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1517\/14656566.2016.1146691","article-title":"Topical amitriptyline and ketamine for post-herpetic neuralgia and other forms of neuropathic pain","volume":"17","author":"Sawynok","year":"2016","journal-title":"Expert Opin Pharmacother"},{"issue":"3","key":"2026053110314648700_pnaf130-B188","doi-asserted-by":"publisher","first-page":"265","DOI":"10.5021\/ad.2018.30.3.265","article-title":"Skin barrier and calcium","volume":"30","author":"Lee","year":"2018","journal-title":"Ann Dermatol"},{"issue":"2","key":"2026053110314648700_pnaf130-B189","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11916-020-00923-2","article-title":"Comprehensive review of topical analgesics for chronic pain","volume":"25","author":"Maloney","year":"2021","journal-title":"Curr Pain Headache Rep"},{"issue":"4","key":"2026053110314648700_pnaf130-B190","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00403-004-0505-0","article-title":"Expression of epidermal N-methyl-D-aspartate receptors (NMDAR1) depends on formation of the granular layer\u2014analysis in diseases with parakeratotic cornification","volume":"296","author":"Fischer","year":"2004","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"2026053110314648700_pnaf130-B191","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jaci.2024.03.006","article-title":"Interactions between skin-resident dendritic and Langerhans cells and pain-sensing neurons","volume":"154","author":"Wilcox","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"2026053110314648700_pnaf130-B192","doi-asserted-by":"publisher","first-page":"390","DOI":"10.2174\/1389201020666191202111534","article-title":"The effectiveness of topical cannabidiol oil in symptomatic relief of peripheral neuropathy of the lower extremities","volume":"21","author":"Xu","year":"2020","journal-title":"Curr Pharm Biotechnol"},{"key":"2026053110314648700_pnaf130-B193","doi-asserted-by":"publisher","first-page":"881617","DOI":"10.3389\/fphar.2022.881617","article-title":"Case report: cannabidiol-induced skin rash: a case series and key recommendations","volume":"13","author":"Souza","year":"2022","journal-title":"Front Pharmacol"},{"issue":"8","key":"2026053110314648700_pnaf130-B194","first-page":"49","article-title":"Safety and sourcing of topical cannabinoids: many questions, few answers","volume":"14","author":"Patel","year":"2021","journal-title":"J Clin Aesthet Dermatol"},{"issue":"3","key":"2026053110314648700_pnaf130-B195","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jconrel.2003.09.001","article-title":"Cannabidiol-transdermal delivery and anti-inflammatory effect in a murine model","volume":"93","author":"Lodzki","year":"2003","journal-title":"J Control Release"},{"issue":"3","key":"2026053110314648700_pnaf130-B196","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1211\/0022357022791","article-title":"Human skin permeation of Delta8-tetrahydrocannabinol, cannabidiol and cannabinol","volume":"56","author":"Stinchcomb","year":"2004","journal-title":"J Pharm Pharmacol"},{"issue":"9","key":"2026053110314648700_pnaf130-B197","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.3109\/03639041003657295","article-title":"Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers","volume":"36","author":"Paudel","year":"2010","journal-title":"Drug Dev Ind Pharm"},{"issue":"4","key":"2026053110314648700_pnaf130-B198","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1089\/can.2021.0154","article-title":"Systematic review on transdermal\/topical cannabidiol trials: a reconsidered way forward","volume":"8","author":"Scholfield","year":"2023","journal-title":"Cannabis Cannabinoid Res"},{"issue":"6","key":"2026053110314648700_pnaf130-B199","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/ejp.818","article-title":"Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis","volume":"20","author":"Hammell","year":"2016","journal-title":"Eur J Pain"},{"issue":"7","key":"2026053110314648700_pnaf130-B200","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.jhsa.2022.03.002","article-title":"A randomized controlled trial of topical cannabidiol for the treatment of thumb basal joint arthritis","volume":"47","author":"Heineman","year":"2022","journal-title":"J Hand Surg Am"},{"issue":"1","key":"2026053110314648700_pnaf130-B201","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1177\/02698811231219060","article-title":"The impact of cannabidiol placebo on responses to an acute stressor: a replication and proof of concept study","volume":"38","author":"Zhekova","year":"2024","journal-title":"J Psychopharmacol"},{"issue":"5","key":"2026053110314648700_pnaf130-B202","doi-asserted-by":"publisher","first-page":"575","DOI":"10.37871\/jbres1482","article-title":"The worldwide herbal market: trends and opportunities","volume":"3","author":"Bareetseng","year":"2022","journal-title":"J Biomed Res Environ Sci"},{"key":"2026053110314648700_pnaf130-B203","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fmed.2020.00031","article-title":"Herbal medicine classification: policy recommendations","volume":"7","author":"Alostad","year":"2020","journal-title":"Front Med (Lausanne)"},{"issue":"Pt A","key":"2026053110314648700_pnaf130-B204","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.fct.2016.11.001","article-title":"An overview of herb and dietary supplement efficacy, safety and government regulations in the United States with suggested improvements. Part 1 of 5 series","volume":"107","author":"Brown","year":"2017","journal-title":"Food Chem Toxicol"},{"issue":"1","key":"2026053110314648700_pnaf130-B205","first-page":"1","article-title":"Evaluation of analgesic activity of Eremostachys laciniata in mice","volume":"9","author":"Delazar","year":"2009","journal-title":"J Natural Remedies"},{"issue":"4","key":"2026053110314648700_pnaf130-B206","doi-asserted-by":"publisher","first-page":"347","DOI":"10.22038\/IJBMS.2018.24026.6021","article-title":"Medicinal herbs in the treatment of neuropathic pain: a review","volume":"21","author":"Forouzanfar","year":"2018","journal-title":"Iran J Basic Med Sci"},{"issue":"14","key":"2026053110314648700_pnaf130-B207","doi-asserted-by":"publisher","DOI":"10.3390\/plants11141797","article-title":"Essential oils and neuropathic pain","volume":"11","author":"Ridouh","year":"2022","journal-title":"Plants (Basel)"},{"issue":"16","key":"2026053110314648700_pnaf130-B208","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.2165\/11640850-000000000-00000","article-title":"Pharmacy compounding primer for physicians: prescriber beware","volume":"72","author":"Sellers","year":"2012","journal-title":"Drugs"},{"issue":"5","key":"2026053110314648700_pnaf130-B209","doi-asserted-by":"publisher","first-page":"309","DOI":"10.7326\/m18-2736","article-title":"Compounded topical pain creams to treat localized chronic pain: a randomized controlled trial","volume":"170","author":"Brutcher","year":"2019","journal-title":"Ann Intern Med"},{"issue":"6","key":"2026053110314648700_pnaf130-B210","first-page":"496","article-title":"Compounded topical gabapentin for neuropathic pain: does choice of base affect efficacy?","volume":"23","author":"Shakshuki","year":"2019","journal-title":"Int J Pharm Compd"},{"issue":"3","key":"2026053110314648700_pnaf130-B211","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics9030031","article-title":"Development and evaluation of topical gabapentin formulations","volume":"9","author":"Martin","year":"2017","journal-title":"Pharmaceutics"},{"issue":"4","key":"2026053110314648700_pnaf130-B212","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.japh.2019.02.012","article-title":"Compounded gabapentin for neuropathic pain: stability and beyond-use date (BUD) in some commonly used bases","volume":"59","author":"Shakshuki","year":"2019","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"2","key":"2026053110314648700_pnaf130-B213","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4212\/cjhp.v73i2.2979","article-title":"Compounded topical amitriptyline for neuropathic pain: in vitro release from compounding bases and potential correlation with clinical efficacy","volume":"73","author":"Shakshuki","year":"2020","journal-title":"Can J Hosp Pharm"},{"issue":"12","key":"2026053110314648700_pnaf130-B214","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s40266-014-0218-9","article-title":"Topical analgesics for neuropathic pain in the elderly: current and future prospects","volume":"31","author":"Sawynok","year":"2014","journal-title":"Drugs Aging"},{"issue":"3 Suppl","key":"2026053110314648700_pnaf130-B215","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.4065\/mcp.2009.0646","article-title":"Treatment considerations for elderly and frail patients with neuropathic pain","volume":"85","author":"Schmader","year":"2010","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"2026053110314648700_pnaf130-B216","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15020349","article-title":"Evaluation of 8% capsaicin patches in chemotherapy-induced peripheral neuropathy: a retrospective study in a comprehensive cancer center","volume":"15","author":"Bienfait","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"2","key":"2026053110314648700_pnaf130-B217","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00115-014-4125-4","article-title":"Schmerzhafte isch\u00e4mische Neuropathie [Painful ischemic neuropathy]","volume":"86","author":"Lang","year":"2015","journal-title":"Nervenarzt"},{"issue":"1","key":"2026053110314648700_pnaf130-B218","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13018-022-03461-2","article-title":"Pain mechanisms in complex regional pain syndrome: a systematic review and meta-analysis of quantitative sensory testing outcomes","volume":"18","author":"Sobeeh","year":"2023","journal-title":"J Orthop Surg Res"},{"issue":"5","key":"2026053110314648700_pnaf130-B219","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.pjnns.2018.08.006","article-title":"Ganglion impar block improves neuropathic pain in coccygodynia: a preliminary report","volume":"52","author":"Sencan","year":"2018","journal-title":"Neurol Neurochir Pol"},{"issue":"1","key":"2026053110314648700_pnaf130-B220","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/grf.0000000000000093","article-title":"Vulvodynia","volume":"58","author":"Edwards","year":"2015","journal-title":"Clin Obstet Gynecol"},{"key":"2026053110314648700_pnaf130-B221","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.2147\/jpr.S136751","article-title":"Vulvodynia is not created equally: empirical classification of women with vulvodynia","volume":"10","author":"Alappattu","year":"2017","journal-title":"J Pain Res"},{"issue":"1","key":"2026053110314648700_pnaf130-B222","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40200-021-00741-2","article-title":"The efficacy and safety profile of capsaicin 8% patch versus 5% lidocaine patch in patients with diabetic peripheral neuropathic pain: a randomized, placebo-controlled study of south Asian male patients","volume":"20","author":"Hussain","year":"2021","journal-title":"J Diabetes Metab Disord"},{"key":"2026053110314648700_pnaf130-B223","author":"Averitas Pharma, Inc","year":"2024"},{"key":"2026053110314648700_pnaf130-B224","author":"Gr\u00fcnenthal GmbH"},{"key":"2026053110314648700_pnaf130-B225","author":"Gr\u00fcnenthal GmbH","year":"2025"}],"container-title":["Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/painmedicine\/advance-article-pdf\/doi\/10.1093\/pm\/pnaf130\/64425899\/pnaf130.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/painmedicine\/article-pdf\/27\/3\/279\/64425899\/pnaf130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/painmedicine\/article-pdf\/27\/3\/279\/64425899\/pnaf130.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T14:31:56Z","timestamp":1780237916000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/painmedicine\/article\/27\/3\/279\/8267720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":225,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,9,29]]},"published-print":{"date-parts":[[2026,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/pm\/pnaf130","relation":{},"ISSN":["1526-2375","1526-4637"],"issn-type":[{"value":"1526-2375","type":"print"},{"value":"1526-4637","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2025,9,29]]}}}